From: 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
 | Baseline, all patients, N=52 | Baseline, analysis cohort, N=31 | Month 6, analysis cohort, N=31 |
---|---|---|---|
Disease activity by physicians’ assessment: absent, mild/moderate, severe, % of patients | |||
 Urticarial skin rash | 71.4, 20.4,4.1 | 67.7, 19.4, 6.5 | 74.2, 25.8, 0.0 |
 Arthralgia | 67.3, 30.6, 2.0 | 67.7, 32.3, 0.0 | 61.3, 29.0, 9.7 |
 Myalgia | 91.8, 6.1, 0.0 | 87.1, 9.7, 0.0 | 83.9, 16.1, 0.0 |
 Conjunctivitis | 71.4, 26.5, 2.0 | 64.5, 32.3, 3.2 | 77.4, 12.9, 6.5 |
 Headaches | 69.4, 22.4, 6.1 | 64.5, 22.6, 9.7 | 61.3, 19.4, 19.4 |
 Abdominal pain | 81.6, 14.3, 4.1 | 83.9, 9.7, 6.5 | 67.7, 22.6, 9.7 |
Patients’ assessment | |||
 Mean disease activity, visual analog scale (VAS) 0–10 | 2.1 | 2.0 | 1.8 |
 Mean Fatigue, VAS 0–10 | 2.6 | 2.5 | 2.7 |
 Impairment of social life, % | 52.6 | 54.5 | 24.0 |